Literature DB >> 21481001

Folic acid rescue of ATRA-induced cleft palate by restoring the TGF-β signal and inhibiting apoptosis.

Zhaoyou Yao1, Dan Chen, Anxun Wang, Xueqiang Ding, Zhonghua Liu, Li Ling, Qianting He, Tingting Zhao.   

Abstract

BACKGROUND: Cleft palate is a frequent congenital malformation with a heterogeneous etiology, for which folic acid (FA) supplementation has a protective effect. To gain more insight into the molecular pathways affected by FA, TGF-β signaling and apoptosis in mouse embryonic palatal mesenchymal (MEPM) cells of all-trans retinoic acid (ATRA)-induced cleft palate in organ culture were tested.
METHODS: C57BL/6J mice embryonic palates were explanted on embryonic day 14 and cultured in DMEM/F12 medium with or without ATRA or FA for 72 h. The palatal fusion was examined by light microscopy. Immunohistochemistry was used to detect TGFβ3/TGF receptor II and caspase 9 in MEPM cells. TUNEL was used to detect apoptosis.
RESULTS: Similar to development in vivo, palatal development and fusion were normal in control medium. ATRA inhibited palatal development and induced cleft palate, which can be rescued by FA. A higher apoptosis rate and caspase-9 in MEPM cells were detected in the ATRA group than in the control or the ATRA+FA group. Compared with the control or the ATRA+FA group, ATRA had little effect on TGF-β3 in MEPM cells but significantly inhibited TGF-β receptor II.
CONCLUSIONS: Folic acid can rescue the cultured palates to continue developing and fusing that were inhibited and resulted in cleft palate by ATRA. Apoptosis and TGFβ signaling in MEPM cells were involved in folic acid rescued ATRA-induced cleft palate.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21481001     DOI: 10.1111/j.1600-0714.2010.00994.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  8 in total

1.  Application research on three-dimensional ultrasonic skeletal imaging mode in detecting fetal upper jaw bone.

Authors:  Li-Peng Zheng; Li-Li Gong; Fang-Chun Guo; Hong-Bo Chang; Guang-Hua Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  Hard to swallow: Developmental biological insights into pediatric dysphagia.

Authors:  Anthony-Samuel LaMantia; Sally A Moody; Thomas M Maynard; Beverly A Karpinski; Irene E Zohn; David Mendelowitz; Norman H Lee; Anastas Popratiloff
Journal:  Dev Biol       Date:  2015-11-07       Impact factor: 3.582

3.  2,3,7,8-Tetrachlorodibenzo-p-Dioxin and TGF-β3 Mediated-Mouse Embryonic Palatal Mesenchymal Cells.

Authors:  Gao Liyun; Jie Xu; Xiao Li; Tao Wang; Weidong Wu; Jia Cao
Journal:  Dose Response       Date:  2018-11-20       Impact factor: 2.658

4.  2,3,7,8-Tetrachlorodibenzo-p-dioxin and TGFβ3-Mediated Mouse Embryonic Palatal Mesenchymal Cells.

Authors:  Liyun Gao; Jie Xu; Xiao Li; Tao Wang; Weidong Wu; Jia Cao
Journal:  Dose Response       Date:  2019-03-03       Impact factor: 2.658

5.  Excessive All-Trans Retinoic Acid Inhibits Cell Proliferation Through Upregulated MicroRNA-4680-3p in Cultured Human Palate Cells.

Authors:  Hiroki Yoshioka; Sai Shankar Ramakrishnan; Junbo Shim; Akiko Suzuki; Junichi Iwata
Journal:  Front Cell Dev Biol       Date:  2021-01-28

6.  Folic Acid Homeostasis and Its Pathways Related to Hepatic Oxidation in Adolescent Rats Exposed to Binge Drinking.

Authors:  María Del Carmen Gallego-Lopez; María Luisa Ojeda; Inés Romero-Herrera; Fátima Nogales; Olimpia Carreras
Journal:  Antioxidants (Basel)       Date:  2022-02-11

7.  MicroRNA-124-3p Plays a Crucial Role in Cleft Palate Induced by Retinoic Acid.

Authors:  Hiroki Yoshioka; Yurie Mikami; Sai Shankar Ramakrishnan; Akiko Suzuki; Junichi Iwata
Journal:  Front Cell Dev Biol       Date:  2021-06-09

Review 8.  Epidemiology, Etiology, and Treatment of Isolated Cleft Palate.

Authors:  Madeleine L Burg; Yang Chai; Caroline A Yao; William Magee; Jane C Figueiredo
Journal:  Front Physiol       Date:  2016-03-01       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.